eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2019-09-25 12 2 1369 1378 10.13005/bpj/1765 28573 article Kanishka Hrishi Das 1 V. Mangayarkarasi 1 Maitrayee Sen 2 Department of Microbiology, SRM Medical College Hospital and Research Centre, Kattankulathur- 603203, Tamil Nadu, India. Department of Gynaecology, SRM Medical College Hospital and Research Centre, Kattankulathur- 603203, Tamil Nadu, India. Vulvovaginal candidiasis (VVC) is caused by Candida species. It has been associated with impact on economic cost. Currently, Non-albicans Candida species are more resistant to azoles and get converted from harmless to pathogenic state due to several virulence factors. Monitoring of the antifungal susceptibility pattern is important to know the resistant pattern of Candida species. Thus the objective of this research was to the identification of Candida in species level and to evaluate the antifungal resistance pattern in Candida species isolated from the vaginal discharge of antenatal women with vulvovaginal candidiasis. This prospective study was done in SRM MCH & RC, Chennai, India, from March 2017 and December 2018. An aggregate of 342 vaginal swabs were gathered from antenatal women of symptomatic and asymptomatic VVC. Antifungal susceptibility test was done by the disk diffusion method as per the CLSI guidelines. A total of 112 Candida species were isolated from 342 high vaginal swabs. Out of 112 Candida isolates, 65 (58%) were Non-albicans Candida (NAC) and 47 (42%) were C. albicans. In this study, 103/112(91.6%) of Candida isolates had the highest sensitivity to voriconazole and 26/112(23.2%) of Candida isolates had the highest resistance to miconazole. NAC species are emerging as potential threats to cause infection and posing a therapeutic challenge. Early empirical antifungal therapy and further research to improve diagnostic, prevention and therapeutic strategies are necessary to reduce the considerable morbidity and mortality. https://biomedpharmajournal.org/vol12no3/antifungal-resistant-in-non-albicans-candida-species-are-emerging-as-a-threat-to-antenatal-women-with-vulvovaginal-candidiasis/ Antifungal Antenatal Women Candida Fluconazole Non-Albicans Candida Resistant Vulvovaginal Candidiasis